Factor Therapeutics is an Australian biotechnology company whose focus has been on developing and commercialising advanced wound care therapies.

Following completion of a randomised Phase 2 clinical trial for venous leg ulcer (VLU) healing, the Company is in the process of evaluating future opportunities.

Factor Therapeutics is a public company traded on the Australian Securities Exchange (ASX:FTT).

For more information please contact info@factor-therapeutics.com